EU Agency Rejects Sanofi, Isis Cholesterol Drug

18.12.2012 - European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol...